TRUMP’S HEALTH SECRETARY NOMINEE IS AN ESTABLISHMENT BIG PHARMA EXEC

Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices!
— Donald J. Trump (@realDonaldTrump) November 13, 2017

President Trump has nominated a former lobbyist and executive of a major pharmaceutical company to be U. S. Health Secretary.
On Monday, Trump announced his pick for Secretary of the Department of Health and Human Services. ‘Happy to announce, I am nominating Alex Azar to be the next HHS Secretary. He will be a star for better healthcare and lower drug prices,’ Trump tweeted. The nominee immediately came under scrutiny for his former connections to the pharmaceutical industry.
Azar formerly served as U. S. Deputy Secretary of Health and Human Services under George W. Bush from 2005 to 2007. In June 2007, Azar began working as a lobbyist for pharmaceutical giant Eli Lilly and Company. Azar also served as Eli Lilly’s spokesman as its Senior Vice President of Corporate Affairs and Communications. Beginning January 1, 2012, Azar was promoted to President of Lilly USA, LLC, the largest division of Eli Lilly and Company – a position which put him in charge of Eli Lilly’s entire U. S. operation.

This post was published at The Daily Sheeple on NOVEMBER 15, 2017.

 

Leave a Reply

Your email address will not be published. Required fields are marked *